Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

International Journal of Molecular Sciences
Ping-Chih HsuLiang You

Abstract

The epidermal growth factor receptor (EGFR) pathway is a well-studied oncogenic pathway in human non-small cell lung cancer (NSCLC). A subset of advanced NSCLC patients (15-55%) have EGFR-driven mutations and benefit from treatment with EGFR-tyrosine kinase inhibitors (TKIs). Immune checkpoint inhibitors (ICIs) targeting the PD-1/PDL-1 axis are a new anti-cancer therapy for metastatic NSCLC. The anti-PD-1/PDL-1 ICIs showed promising efficacy (~30% response rate) and improved the survival of patients with metastatic NSCLC, but the role of anti-PD-1/PDL-1 ICIs for EGFR mutant NSCLC is not clear. YAP (yes-associated protein) is the main mediator of the Hippo pathway and has been identified as promoting cancer progression, drug resistance, and metastasis in NSCLC. Here, we review recent studies that examined the correlation between the EGFR, YAP pathways, and PD-L1 and demonstrate the mechanism by which EGFR and YAP regulate PD-L1 expression in human NSCLC. About 50% of EGFR mutant NSCLC patients acquire resistance to EGFR-TKIs without known targetable secondary mutations. Targeting YAP therapy is suggested as a potential treatment for NSCLC with acquired resistance to EGFR-TKIs. Future work should focus on the efficacy of YAP inhi...Continue Reading

References

Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
Sep 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yoshiko IwaiNagahiro Minato
Sep 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fred R HirschWilbur A Franklin
May 15, 2004·International Journal of Radiation Oncology, Biology, Physics·Roy S Herbst
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
Feb 28, 2006·Trends in Immunology·Taku Okazaki, Tasuku Honjo
Feb 24, 2007·Nature Reviews. Cancer·Sreenath V SharmaDaniel A Haber
Sep 8, 2007·Cell Death and Differentiation·S A DanoviS Basu
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Jun 4, 2010·Biochemical Pharmacology·Takeshi YoshidaEric B Haura
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Feb 9, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ZielinskiF Hirsch
Mar 15, 2013·Developmental Cell·B V V G Reddy, Kenneth D Irvine
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Dec 18, 2013·Nature Reviews. Drug Discovery·Randy Johnson, Georg Halder
Feb 4, 2014·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Haruhisa KitanoStephen M Hewitt
Jun 16, 2014·Nature Cell Biology·David RomanoWalter Kolch
Jun 24, 2014·Cell·Diane D ShaoWilliam C Hahn
Jul 2, 2014·Nature Reviews. Clinical Oncology·D Ross CamidgeLecia V Sequist
Jul 6, 2014·Cell·Florian R Greten
Aug 8, 2014·Journal of Cellular and Molecular Medicine·Luis Paz-AresBarbara Klughammer
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Feb 6, 2015·International Journal of Oncology·Liwen Guo, Lisong Teng
Feb 7, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nan ChenLi Zhang
Feb 26, 2015·Journal of Cellular and Molecular Medicine·Xiang-Yun YeZhi-Wei Chen

❮ Previous
Next ❯

Citations

Oct 28, 2019·Pharmaceutics·Rossella FarraGabriele Grassi
Oct 2, 2020·Molecular Medicine Reports·Liya JiangJun Lin
Apr 15, 2020·Cancers·Abdulaziz B Hamid, Ruben C Petreaca
Oct 31, 2020·Frontiers in Cell and Developmental Biology·Qiang GuoGang Xu
Jan 3, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Filippo de MarinisDariusz Kowalski
Jan 14, 2021·International Journal of Molecular Sciences·Alexandru OpritaAni-Simona Sevastre
Dec 3, 2020·Frontiers in Oncology·Tianhao ZhuSibo Zhu
Jan 29, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Juan ZhouChunxia Su
Feb 15, 2020·Pathology, Research and Practice·Zhu LinglingZhou Qinghua
Mar 16, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jia LiuSteven Kao
Mar 30, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rui-Fang DongLing-Yi Kong
Apr 30, 2021·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Meng QiaoCaicun Zhou
Aug 28, 2021·International Journal of Molecular Sciences·Reem Nooreldeen, Horacio Bach
Oct 9, 2020·Signal Transduction and Targeted Therapy·Siyuan QinWeifeng He
Nov 17, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Matthew J HadfieldAswanth Reddy
Nov 28, 2021·International Journal of Molecular Sciences·Sarah Sayed HassaneinAhmed Lotfy Abdel-Mawgood

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation

Clinical Trials Mentioned

NCT03430063
NCT02155647
NCT02039674
NCT02864251
NCT03515837

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.